The only controlled study suggests that initial prednisone doses ≤ 10 mg is associated with high incidence of recurrences, whereas doses ≥ 20 mg are associated with considerable side effects.

Objective: A randomised double-blind placebo controlled withdrawal clinical trial of prednisone versus placebo in patients with rheumatoid arthritis (RA), treated in usual clinical care with 1–4 ...

b During this visit, the patient was prescribed prednisone 10 mg orally daily and his warfarin dosage was decreased to 9 mg weekly. c During this visit, the patient’s warfarin dosage was ...

Doctors are warning about the unusual symptoms of a rare parasitic infection that is common in Hawaii. A New England woman ...

charite.de Objective To assess the efficacy and safety of low-dose prednisone chronotherapy using a new modified-release (MR) formulation for the treatment of rheumatoid arthritis (RA). Methods In ...

Taking prednisone ... of taking a dose. People taking steroids need to regularly monitor their blood sugar levels and take oral medication or insulin if these levels become too high.

Among those who adhered to treatment, the high-dose group achieved an average weight loss of 20.7%, compared to 17.5% with the lower dose and 2.4% in the placebo group. For the overall group ...

at the same time that melatonin serum levels are highest and plasma cortisol is lowest. In any case, long-term exogenous glucocorticoid administration may interfere with the HPA axis function and with ...

A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...

A high dose of Novo Nordisk’s obesity drug Wegovy caused more weight loss than the approved regimen in a Phase III trial, the company said Friday. However, the data suggest Eli Lilly’s rival GLP-1 ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with competitor Eli Lilly’s Zepbound.